Opportunity Information: Apply for RFA DE 18 010

The National Institutes of Health (NIH) offered this discretionary grant opportunity, titled "Biology Of Aging Dental, Oral And Craniofacial Tissues (R21 - Clinical Trial Not Allowed)" (Funding Opportunity Number RFA-DE-18-010; CFDA 93.121), to push forward early-stage, collaborative research focused on how aging changes dental, oral, and craniofacial (DOC) tissues. The central idea behind the announcement is that the mouth and craniofacial complex do not age in isolation. Many of the same biological processes that drive aging in other organs and tissues also affect gums, bone, salivary glands, oral mucosa, and related craniofacial structures. By encouraging studies that directly connect DOC aging to broader, body-wide aging biology, the program aimed to close fundamental knowledge gaps that ultimately limit prevention and treatment strategies for older adults.

The FOA’s scientific emphasis was on three intersecting themes that are widely implicated in aging and age-related disease: inflammation, tissue healing and regeneration, and epigenetic regulation. In practice, this means the program was looking for projects that explain how chronic or dysregulated inflammatory signaling changes with age in oral and craniofacial tissues, how aging alters the ability of these tissues to repair themselves after injury or disease, and how epigenetic mechanisms (such as DNA methylation, histone modifications, chromatin remodeling, and related gene-expression controls) shift over time and contribute to functional decline. A key feature is the encouragement of cross-tissue or cross-organ comparisons, meaning applicants were expected to think about parallels between DOC tissues and other biological systems rather than treating oral aging as a siloed topic.

The long-term public health goal was improved oral health for older adults, but the FOA was positioned as basic and mechanistic rather than clinical. It sought foundational discoveries that could explain why age-associated changes increase susceptibility to disease, slow recovery, or worsen outcomes in DOC tissues. By targeting underlying biology, the program intended to set up future translational work that could inform better diagnostics, preventive strategies, and therapies for conditions that become more common or more severe with age, including impaired wound healing, chronic inflammatory states, and degeneration of supporting tissues.

This was an R21 mechanism, which is typically used to support exploratory or developmental research projects that are at an earlier stage, potentially higher-risk, and aimed at generating strong preliminary data or testing innovative concepts. The award ceiling listed is $200,000, reflecting the smaller, pilot-like scale commonly associated with R21 grants. Importantly, the announcement explicitly stated "Clinical Trial Not Allowed," meaning applicants could not propose clinical trials as part of the work under this FOA. The intent was to keep projects focused on biological mechanisms and preclinical or non-trial human research approaches, rather than interventional studies that meet the definition of a clinical trial.

Eligibility was broad and included many types of organizations. In addition to standard applicants such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), and small businesses, the FOA also welcomed applications from a wide range of government and community entities. Eligible applicants included state, county, and local governments; special district governments; independent school districts; public housing authorities and Indian housing authorities; federally recognized tribal governments; and tribal organizations that are not federally recognized. The announcement also highlighted additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, U.S. territories or possessions, regional organizations, eligible federal agencies, and even non-U.S. entities (foreign organizations). This breadth signals a clear interest in drawing expertise from many sectors and encouraging diverse research settings and collaborations.

From a timing and administrative standpoint, the opportunity was created on 2017-09-19, with an original closing date of 2018-02-28. The funding instrument type was a grant, and the activity category was health. While the notice lists "ExpectedAwards" without a number, the overall structure is consistent with an NIH initiative designed to seed multiple exploratory projects rather than fund a single large program.

In summary, this FOA was designed to catalyze innovative, collaborative, non-clinical-trial research that explains how and why DOC tissues change with age, with special attention to inflammatory pathways, regenerative capacity, and epigenetic regulation. By strengthening the basic science foundation of oral and craniofacial aging and tying it to broader aging biology, the program aimed to build a clearer path toward improving health outcomes for older adults.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Biology Of Aging Dental, Oral And Craniofacial Tissues (R21 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121.
  • This funding opportunity was created on 2017-09-19.
  • Applicants must submit their applications by 2018-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DE 18 010

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the title of this NIH funding opportunity?

The funding opportunity is titled "Biology Of Aging Dental, Oral And Craniofacial Tissues (R21 - Clinical Trial Not Allowed)."

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is RFA-DE-18-010.

What CFDA program is associated with this opportunity?

The CFDA number listed is 93.121.

What is the overall purpose of this FOA?

This FOA is intended to advance early-stage, collaborative research focused on understanding how aging changes dental, oral, and craniofacial (DOC) tissues. It emphasizes connecting DOC aging to broader, body-wide biology of aging rather than treating oral aging as an isolated topic.

What types of tissues or systems are included under "dental, oral, and craniofacial (DOC) tissues"?

The FOA references DOC tissues and related craniofacial structures, including gums, bone, salivary glands, and oral mucosa, as examples of tissues impacted by aging.

Is this opportunity focused on basic science or clinical research?

It is positioned as basic and mechanistic rather than clinical. The goal is foundational discovery about biological mechanisms that drive age-associated changes in DOC tissues.

Are clinical trials allowed under this FOA?

No. The FOA explicitly states "Clinical Trial Not Allowed," meaning applications cannot propose clinical trials under this program.

If clinical trials are not allowed, what kind of research approaches does the FOA support?

Based on the FOA description, the intent is to support mechanistic and foundational work, including preclinical or non-trial human research approaches, to explain age-related changes in DOC tissues. The program is aimed at biology and mechanisms rather than interventions that meet the definition of a clinical trial.

What grant mechanism is used for this opportunity?

This opportunity uses the NIH R21 mechanism, which is typically used for exploratory or developmental research projects.

What does the R21 mechanism imply about the project stage and risk level?

The R21 mechanism is described as supporting earlier-stage, potentially higher-risk projects designed to test innovative ideas and generate strong preliminary data.

What is the award ceiling for this R21?

The award ceiling listed is $200,000.

What scientific themes does this FOA prioritize?

The FOA emphasizes three intersecting themes widely implicated in aging and age-related disease: inflammation, tissue healing and regeneration, and epigenetic regulation.

What does the FOA mean by focusing on inflammation in DOC tissue aging?

It highlights interest in understanding how chronic or dysregulated inflammatory signaling changes with age in oral and craniofacial tissues and how those changes contribute to functional decline or disease susceptibility.

What does the FOA mean by focusing on tissue healing, repair, and regeneration?

It seeks studies explaining how aging alters the ability of DOC tissues to repair themselves after injury or disease, including why recovery may slow or outcomes may worsen with age.

What epigenetic mechanisms are specifically mentioned in the FOA?

The FOA mentions epigenetic regulation mechanisms such as DNA methylation, histone modifications, chromatin remodeling, and related controls of gene expression that shift over time and may contribute to age-related functional decline.

Does the FOA encourage cross-tissue or cross-organ comparisons?

Yes. A key feature is encouragement of cross-tissue or cross-organ comparisons, with the expectation that applicants will examine parallels between DOC tissues and other biological systems to connect oral aging to broader aging biology.

What types of problems or conditions is this FOA ultimately trying to address?

The long-term public health goal is improved oral health for older adults. The FOA frames this through foundational work that could later inform better diagnostics, preventive strategies, and therapies for age-associated issues such as impaired wound healing, chronic inflammatory states, and degeneration of supporting tissues.

Who can apply for this grant opportunity?

Eligibility is broad and includes public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; and a wide range of government and community entities.

Are state, local, and tribal government entities eligible to apply?

Yes. The FOA lists eligible applicants including state, county, and local governments; special district governments; independent school districts; public housing authorities and Indian housing authorities; federally recognized tribal governments; and tribal organizations that are not federally recognized.

Are minority-serving institutions and community-based organizations eligible?

Yes. The FOA explicitly highlights eligibility for Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving Institutions, HBCUs, TCCUs, as well as faith-based or community-based organizations.

Are U.S. territories and regional organizations eligible?

Yes. The FOA includes U.S. territories or possessions and regional organizations among the eligible categories.

Are federal agencies eligible to apply?

Yes. The FOA lists eligible federal agencies as eligible applicants.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The FOA indicates that non-U.S. entities (foreign organizations) are eligible.

What is the funding instrument type and activity category?

The funding instrument type is a grant, and the activity category is health.

When was this funding opportunity created and when did it close?

The opportunity was created on 2017-09-19, and the original closing date listed is 2018-02-28.

How many awards were expected?

The notice lists "ExpectedAwards" but does not provide a specific number. The description suggests an NIH initiative structured to seed multiple exploratory projects rather than fund a single large program.

What kind of outcomes was this FOA designed to produce?

It was designed to catalyze innovative, collaborative, non-clinical-trial research that explains how and why DOC tissues change with age, especially through inflammatory pathways, regenerative capacity, and epigenetic regulation, and to build a foundation for future translational work.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: USAID/DRC Request for Information: Responsible Minerals Program Planning

Previous opportunity: Cellular and Molecular Biology of Complex Brain Disorders (R21)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DE 18 010

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DE 18 010) also looked into and applied for these:

Funding Opportunity
Collaborative Program Grant for Multidisciplinary Teams (RM1) Apply for PAR 17 340

Funding Number: PAR 17 340
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Valid Reliable Markers of Aging-Related Biologic Mechanisms for Human Studies (U01) Apply for RFA AG 18 018

Funding Number: RFA AG 18 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required) Apply for PAR 18 304

Funding Number: PAR 18 304
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 - Clinical Trial Not Allowed) Apply for PAR 18 402

Funding Number: PAR 18 402
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 - Clinical Trial Not Allowed) Apply for PAR 18 403

Funding Number: PAR 18 403
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Amplify Family Planning and Sexual and Reproductive Health Activity (AMPLIFY-FP)) Apply for RFI 624 18 000001

Funding Number: RFI 624 18 000001
Agency: West Africa USAID-Ghana
Category: Health
Funding Amount: $18,500,000
National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32) Apply for PAR 17 341

Funding Number: PAR 17 341
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) Apply for RFA CA 17 048

Funding Number: RFA CA 17 048
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,200,000
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 18 319

Funding Number: PAR 18 319
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) Apply for RFA CA 17 047

Funding Number: RFA CA 17 047
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional) Apply for PA 18 322

Funding Number: PA 18 322
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional) Apply for PA 18 323

Funding Number: PA 18 323
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Announcement of Anticipated Availability of Funds for Support for Expectant and Parenting Teens, Women, Fathers, and Their Families Apply for AH SP1 18 001

Funding Number: AH SP1 18 001
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $1,000,000
NHLBI Program Project Applications (P01 - Clinical Trials Optional) Apply for PAR 18 405

Funding Number: PAR 18 405
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) Apply for RFA AI 17 034

Funding Number: RFA AI 17 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 329

Funding Number: PAR 18 329
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 326

Funding Number: PAR 18 326
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Immunity in the Elderly (R01) Clinical Trial Optional Apply for RFA AI 17 037

Funding Number: RFA AI 17 037
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) Apply for RFA AG 18 019

Funding Number: RFA AG 18 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 18 406

Funding Number: PAR 18 406
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DE 18 010", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: